“Universal Flu Vaccine” Unveiled by DHHS
On May 1, 2025, the U.S. Department of Health and Human Services (DHHS) announced plans to develop a universal influenza vaccine that would eliminate the need for annual flu shots and offer protection against other pandemic influenza threats, including bird flu and respiratory disease caused by coronaviruses. The initiative, called “Generation Gold Standard,” will cost […]
NIH Cuts Funding for “Vaccine Hesitancy” Research
Certain areas of research funded by the U.S. National Institutes of Health (NIH) is being reduced or discontinued with the justification that these areas no longer align with the agency’s current priorities. One of the areas in which funding will be cut is millions of dollars in NIH grants for studying vaccine hesitancy and strategies […]
Study Finds Sudden Infant Deaths Have Increased
A new study published in the Journal of the American Medical Association (JAMA) last month has found that rates of Sudden Infant Death Syndrome (SIDS) increased 12 percent during 2020-2022, during the height of the coronavirus pandemic. SIDS is the unexplained death of an otherwise healthy infant, typically occurring in babies under one year old. […]
Senator Hawley Applauds Trump-Backed NIH Nominee for Ensuring Ethical Vaccines, Challenging Big Pharma
I will absolutely follow the lead of Secretary Kennedy and President Trump on [prohibiting the use of aborted tissue in NIH-funded research]. During the pandemic, I would often be on Catholic radio, and people would ask me whether the mRNA vaccines were made or developed with aborted fetal stem cell lines, and I had to […]
DHHS Secretary RFK, Jr. and USDA Secretary Both Say “No” to Bird Flu Vaccine for Chickens
Opinion | Secretary of Health and Human Services Robert F. Kennedy, Jr announced on Mar. 4, 2025 that the avian influenza (“bird flu”) vaccine should not be given to chickens in the U.S. based on emerging evidence that injecting poultry with avian influenza virus (AIV) vaccine could lead to mutations accelerating evolution of the animal […]
FDA Clears Investigational New Drug Application for Inhaled COVID Biologic
Biotech company Ocugen, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared their Investigational New Drug (IND) application for a novel inhaled vaccine against SARS-CoV-2. The biologic uses novel chimpanzee adenovirus-vectored (ChAd36) technology. The approval will allow the company to initiate Phase I clinical trials for the inhaled vaccine, OCU500. The […]